You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞生物科技(01548.HK)旗下兩企引資高瓴資本 下午復牌
阿思達克 05-14 12:27
金斯瑞生物科技(01548.HK)公布,公司與投資者高瓴資本管理就公司間接全資附屬Probio Cayman建議A輪融資訂合約細則。公司將於Probio A輪融資完成前透過其附屬Probio BVI認購金額為7,000萬美元可轉換為Probio股份的可換股債券。而高瓴資本將認購A輪融資總投資額1.5億美元的Probio Cayman A類優先股。

公司將向高瓴資本發行Probio認股權證,可於Probio A輪融資完成起計24個月內行使,以按等於初始購買價1.32倍的每股價格(最多合共1.25億美元)購買Probio認股權證股份。

A輪融資完成後,公司全資附屬Probio BVI於Probio Cayman的股權將攤薄至82.95%(假設可換股債券未轉換為Probio股份)。

另外,公司持股的傳奇生物同意向買方LGN Holdings(唯一投資管理人為高瓴資本管理)發行及出售合共近2,081萬股傳奇股份,總代價為3億美元;及向買方發行認股權證,可向傳奇生物認購及購買最多合共1,000萬股傳奇股份,總行使價為2億美元。完成後,公司於傳奇生物的股權將由64.31%,攤薄至58.31%。

Probio Cayman擬將A輪融資所得款項淨額用作營運資金,主要用於擴大生產設施、加強研發平台以及一般企業開支。傳奇生物擬將購買事項所得款項淨額用作營運資金,主要用於研發及商業化其管線項目及擴大生產設施、加強研發平台以及一般企業開支。

應公司要求,公司股份已自今日(14日)上午9時正起短暫停牌。公司已向聯交所申請本公司股份自今日下午恢復買賣。(ek/u)

~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account